Cargando…
Dapsone-Associated Anemia in Heart Transplant Recipients with Normal Glucose-6-Phosphate Dehydrogenase Activity
Dapsone is considered an alternative for pneumocystis jirovecii pneumonia (PJP) prophylaxis in sulfa-allergic or -intolerant transplant patients with normal glucose-6-phosphate dehydrogenase (G6PD) activity. Despite normal G6PD activity, anemia can still occur while on dapsone therapy. We retrospect...
Autores principales: | Lor, Kevin W., Kransdorf, Evan P., Patel, Jignesh K., Chang, David H., Kobashigawa, Jon A., Kittleson, Michelle M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658039/ https://www.ncbi.nlm.nih.gov/pubmed/36362606 http://dx.doi.org/10.3390/jcm11216378 |
Ejemplares similares
-
Successful Treatment of Severe COVID-19 Pneumonia With Clazakizumab in a Heart Transplant Recipient: A Case Report
por: Vaidya, Gaurang, et al.
Publicado: (2020) -
Early Denervation and Later Reinnervation of the Heart Following Cardiac Transplantation: A Review
por: Awad, Morcos, et al.
Publicado: (2016) -
Atypical cardiac amyloidosis phenotypes identified at transplant: a case series
por: Rushakoff, Joshua A, et al.
Publicado: (2023) -
Characteristics, outcomes, and predictors of de novo malignancy after heart transplantation
por: Youn, Jong-Chan, et al.
Publicado: (2022) -
Management of the ACC/AHA Stage D Patient: Cardiac Transplantation
por: Kittleson, Michelle M., et al.
Publicado: (2014)